---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-23-030245"
form_type: "8-K"
ticker: "BCTX"
cik: "0001610820"
company_name: "BriaCell Therapeutics Corp."
filed_at: "2023-08-25T23:59:59+00:00"
generated_at: "2026-06-11T03:32:03.536996+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# BriaCell gets court approval for spin-out of BriaPro Therapeutics, effective Aug 31, 2023

## Summary
- Court approved spin-out of BriaPro Therapeutics with pipeline assets including Bria-TILsRx and PKCδ inhibitors.
- Effective date expected August 31, 2023; SpinCo to be ~2/3 owned by BriaCell and ~1/3 by BriaCell shareholders.
- Shareholders receive one SpinCo share and one new BriaCell share for each old share held.
- BriaCell remains listed on Nasdaq and TSX; SpinCo to be unlisted reporting issuer in Canada.

## SEC filing metadata
- accession: 0001493152-23-030245
- form_type: 8-K
- ticker: BCTX
- cik: 0001610820
- company_name: BriaCell Therapeutics Corp.
- filed_at: 2023-08-25T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1610820/000149315223030245/0001493152-23-030245-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1610820/000149315223030245/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-23-030245
- JSON: https://secwatch.observer/filing/0001493152-23-030245.json
- Plain text: https://secwatch.observer/filing/0001493152-23-030245.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.